The standard treatments and advance of medication in soft-tissue sarcomas

SUN Yuan-jue,YAO Yang
DOI: https://doi.org/10.3969/j.issn.1007-3639.2012.09.002
2012-01-01
Abstract:Soft-tissue sarcomas(STS) represent a large heterogeneous group of mesoderm-derived tumors.Surgery is the base of comprehensive treatment,but more than 50% of STS patients trend to metastasis to other organs and lost opportunity of radical resection.Local radiation can reduce post-operation local recurrence;chemotherapy and molecular target treatment are systemic treatment and play an important roles in comprehensive treatment.Chemotherapy and molecular target treatment represent active roles in the fields of lowering tumor recurrence,reducing tumor metastasis,increasing survival rate and improving quality of life.
What problem does this paper attempt to address?